2. 2
FNH - HA
Αλαγλσξίδνληαη νινέλα θαη πην ζπρλά
Πξόζθαηεο ηερλνινγηθέο εμειίμεηο ζηελ απεηθόληζε
Δπξεία ρξήζε ηνπο ζηελ θαζεκεξηλή θιηληθή πξάμε
Σπραίν εύξεκα ρσξίο εηδηθά ζπκπηώκαηα
σζηή δηάγλσζε:
α. Αηηηνπαζνγέλεηα
β. Θεξαπεία
γ. Πξόγλσζε
“ …it is sometimes difficult to differentiate a benign liver mass from a
malignant tumor without definitive histological proof…“
Miroslav Milisevic, Stockholm 2008
3. 3
EVIDENCE-BASED SURGERY
…No RCTs
... No evidence supporting or refuting elective surgery for patients with
benign liver tumors…
…Large, long-term, randomized clinical trials with adequate
methodology needed to assess the benefits and harms of elective
surgery…
…Elective surgery is controversial and indications are represented by
uncertain diagnosis, presence of symptoms and prevention of major
complications…
Colli et al. Elective surgery for benign liver tumors.
Cochrane Database of Systematic Reviews 2007
24. 24
ΖΠΑΣΟΚΤΣΣΑΡΗΚΟ ΑΓΔΝΩΜΑ (ΖΑ)
Μνξηαθή Βηνινγία HA
Group 1: HAs with Mutations in the
HNF1A Gene
Group 2: HAs with Mutations of the
β-Catenin Gene
Group 3: Inflammatory HAs
Group 4: HAs without Markers